Hwang Suk Cells Quotations

Technology for patient-specific embryonic stem cells belongs to South Korea. And you will find out that this is true.

Our research team made patient-specific embryonic stem cells and we have the technology to produce them.

There is no doubt that we produced 11 patient-specific stem cells and possess the core technology to create them again.

I apologize for creating this uproar both in and out of Korea. The fact remains that our research team was successful in creating stem cells from patients' skin cells. Still, there were mistakes made, human errors, in taking photographs and in the preservation of the stem cells.

When the use of these stem cells is limited to a particular country, it takes much too long to create technologies usable for the whole humanity. By creating a global network, we plan to share stem cells created in each country and share information on those stem cells.